TEVA-BUDESONIDE

Google image searchProduct monograph

Active ingredient

budesonide, 0.125 MG/ML

DIN: 02465949

Dosage form(s): SUSPENSION

Route(s) of administration: INHALATION

Schedule: Prescription

Company: TEVA CANADA LIMITED

Date: 08-NOV-2017

ATC:

Reference brand drug: Rhinocort

Pharmaceutical standard: MFR

Search on Google

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find teva-budesonide photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.